Deliver Your News to the World

Wyeth’s Pearl River, N.Y. Facility Celebrates 100 Years of Achievements in Health Care


Pearl River, N.Y.– Wyeth (NYSE: WYE) today kicks off the 100th anniversary celebration of its Pearl River, N.Y., research and manufacturing facility, honoring the generations of employees at the site who have contributed to significant advances in medical science and human health.

The 550-acre complex, located in Rockland County approximately 20 miles north of New York City, employs approximately 3,200 people and is one of the largest manufacturing and research facilities in Wyeth’s global network. It is a recognized leader in the discovery, development and manufacture of a wide range of innovative health care products, including pharmaceuticals, vaccines, biotechnology products and non-prescription consumer products.

“The history of Pearl River closely mirrors the history of the modern pharmaceutical industry,” says Charles Portwood, president Technical Operations & Product Supply (TO&PS). “Over the years, it has been associated with many of the important medical advances and accomplishments in the health care field. And it continues to produce some of Wyeth’s most sophisticated products and to pioneer manufacturing innovations that are used across the Wyeth network.”

Numerous medical milestones are associated with Pearl River. The site pioneered the production of tetanus antitoxin and was a major manufacturing center for typhoid, smallpox and polio vaccines. And it was researchers at Pearl River who discovered Aureomycin chlortetracycline, one of the first broad-spectrum antibiotics. The site also manufactured the company’s first FDA-licensed product – diphtheria antitoxin.

“We are extremely proud of the contributions that Pearl River has made to improving health here in the United States and around the world,” says Robert Ruffolo, president of Wyeth’s Research & Development unit. “The work of researchers at the site has led to the development of breakthrough therapies to fight serious infections and diseases and to promote global health.”

Today, the Pearl River facility is responsible for producing a number of Wyeth’s leading products. Included are such products as Prevnar®, (Pneumococcal 7-valent Conjugate Vaccine [Diptheria CRM197 Protein]) and Centrum®.

In 2006, the Pearl River site received the Wyeth President’s Award for Environment, Health and Safety (EHS) Excellence and became the first site to receive the Company’s highest EHS award two times.

The site is a strong supporter of the Rockland County United Way and several community-based organizations that provide support for people in need. In addition, Pearl River is a corporate sponsor and host site of key fund raising events for the regional chapters of two well-known nonprofit organizations: the Annual Centrum Walk/Run and Prevnar Kids Run, which supports the March of Dimes in its work to fight premature births, and the Walk to Cure Diabetes, which supports the efforts of the Juvenile Diabetes Research Foundation.

As part of the Pearl River anniversary celebration, Wyeth is donating $500,000 to the Children’s Health Fund’s (CHF) Urban Health Initiative. The donation will assist the more than one in five children that live in poverty – which totals more than 15 million boys and girls in the United States – obtain better health care services.


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.